Literature DB >> 12189166

Identification of the autoantigen SART-1 as a candidate gene for the development of atopy.

Amanda P Wheatley1, Daniel J Bolland, Jane E Hewitt, Jane C Dewar, Ian P Hall.   

Abstract

The possibility that immune responses to autoantigens may contribute to the development of atopic disease has been largely ignored. In this paper, we describe the chromosomal localization of the gene for squamous cell carcinoma-associated reactive antigen for cytotoxic T cells (SART-1). The SART-1 gene localized to a region of 11q12-13 showing strong linkage to atopy in previous studies. Further analysis of this gene revealed the presence of at least 20 exons of varying lengths and four novel single-nucleotide polymorphisms, one of which resulted in an amino acid substitution. Association analysis in families recruited on the basis of affected sib pairs for asthma reveal significant association for both coding region polymorphisms with atopy. We therefore hypothesize that polymorphic variation within the SART-1 gene may account for individuals developing atopy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189166     DOI: 10.1093/hmg/11.18.2143

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  2 in total

1.  A sequence variant on 17q21 is associated with age at onset and severity of asthma.

Authors:  Eva Halapi; Daniel F Gudbjartsson; Gudrun M Jonsdottir; Unnur S Bjornsdottir; Gudmar Thorleifsson; Hafdis Helgadottir; Carolyn Williams; Gerard H Koppelman; Andrea Heinzmann; H Marike Boezen; Aslaug Jonasdottir; Thorarinn Blondal; Sigurjon A Gudjonsson; Adalbjorg Jonasdottir; Theodora Thorlacius; Amanda P Henry; Janine Altmueller; Marcus Krueger; Hyoung Doo Shin; Soo-Taek Uh; Hyun Sub Cheong; Brynja Jonsdottir; Bjorn R Ludviksson; Dora Ludviksdottir; David Gislason; Choon-Sik Park; Klaus Deichmann; Philip J Thompson; Matthias Wjst; Ian P Hall; Dirkje S Postma; Thorarinn Gislason; Augustine Kong; Ingileif Jonsdottir; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Eur J Hum Genet       Date:  2010-04-07       Impact factor: 4.246

2.  Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer.

Authors:  Akira Yamada; Masanori Noguchi; Nobukazu Komatsu; Shigetaka Suekane; Shigeru Yutani; Fukuko Moriya; Takashi Mine; Kosuke Momozono; Koichiro Kawano; Kyogo Itoh
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.